ddPCR Assay Development for AAV GMP Quality Control

David Ren, PhD
Director of Analytical Science & Technology, Global QC in Novartis Gene Therapies
Dr. Ren is currently Director of Analytical Science & Technology, Global QC in Novartis Gene Therapies. Dr. Ren was medically trained and later received his PhD in Molecular Biology from the University of Oxford. He started bio‑analytical career in 2008 when he developed a PCR clamp technology for rare mutation detection. Dr. Ren has rich experience in PCR assay development & validation, and in testing operation management. In the recent years, he is focused on the QC analytics for AAV Production.
Get Access to this Webinar
Share a little information with us to access this webinar.
Required fields